(Updated - April 16, 2026 7:44 AM EDT)

Guggenheim analyst Vamil Divan raised the price target on Insmed (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE